12
Participants
Start Date
April 28, 2020
Primary Completion Date
December 30, 2023
Study Completion Date
March 15, 2024
Control group
Patients randomized into this group will receive standard of care for COVID-19 infection
SLEDD with a L-MOD
Patients randomized to this group will undergo slow low efficiency daily dialysis for approximately 12 hours, 2 days in a row with a leukocyte modulatory device.
University Hospital, London
Victoria Hospital - Critical Care Trauma Centre, London
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
OTHER